The role of magnetic resonance imaging in prostate cancer imaging and staging

Robert E. Lenkinski

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Scopus citations

Abstract

MRI of the prostate can be used to address several of the clinical issues associated with diagnosing and treating prostate cancer. We have found dynamic contrast enhanced MRI (DCEMRI) to be valuable tool in visualizing and characterizing malignancies. Our approach is based on the threetime point method (3TP), which is a simplified model based method for analyzing DCEMRI of the prostate. This method is a high-spatial, low temporal resolution approach. We have found that this approach can be combined with more conventional MRI methods to give highly accurate staging of prostate cancer. An unanticipated clinical benefit has been the ability to use DCEMRI to image men with elevated PSA and repeat negative biopsy. We have also used a model independent approach based on principal component analysis (PCA) to analyze the DCEMRI datasets.

Original languageEnglish (US)
Title of host publication2011 8th IEEE International Symposium on Biomedical Imaging
Subtitle of host publicationFrom Nano to Macro, ISBI'11
Pages2109-2112
Number of pages4
DOIs
StatePublished - Nov 2 2011
Event2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI'11 - Chicago, IL, United States
Duration: Mar 30 2011Apr 2 2011

Publication series

NameProceedings - International Symposium on Biomedical Imaging
ISSN (Print)1945-7928
ISSN (Electronic)1945-8452

Other

Other2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI'11
CountryUnited States
CityChicago, IL
Period3/30/114/2/11

ASJC Scopus subject areas

  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'The role of magnetic resonance imaging in prostate cancer imaging and staging'. Together they form a unique fingerprint.

  • Cite this

    Lenkinski, R. E. (2011). The role of magnetic resonance imaging in prostate cancer imaging and staging. In 2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI'11 (pp. 2109-2112). [5872829] (Proceedings - International Symposium on Biomedical Imaging). https://doi.org/10.1109/ISBI.2011.5872829